Blog

Shares of TeraWulf Inc. (WULF) have gained 18% over the past four weeks to close the last trading session at $5.11, but there could still be a solid upside left in the stock if short-term price

Exact Sciences (EXAS) closed the last trading session at $54.3, gaining 1.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Shares of Rapt Therapeutics (RAPT) have gained 5.8% over the past four weeks to close the last trading session at $8.72, but there could still be a solid upside left in the stock if short-term price

Zevra Therapeutics (ZVRA) closed the last trading session at $12.79, gaining 40.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Astrana Health, Inc. (ASTH) closed the last trading session at $25.12, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

After reaching an important support level, Artisan Partners Asset Management Inc. (APAM) could be a good stock pick from a technical perspective. APAM recently experienced a "golden cross" event

A downtrend has been apparent in Novozymes A/S (NVZMY) lately. While the stock has lost 5.6% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in its

From a technical perspective, Oric Pharmaceuticals, Inc. (ORIC) is looking like an interesting pick, as it just reached a key level of support. ORIC's 50-day simple moving average crossed above its

Corpay, Inc. CPAY stock has had a decent run in the past three months. Shares of the company have gained 6.4%, outperforming the industry’s 4.7% growth.

Image Source: Zacks Investment Research

BP plc BP and Eni SpA’s E joint venture, Azule Energy, has encountered gas in an offshore block in Angola. Angola’s National Agency of Petroleum, Gas and Biofuels (“ANPG”) stated that the gas

Digital Realty DLR shares have risen 15.4% in the past three months compared with the industry’s 5.3% growth.

Amid robust demand for data centers, the company is poised for growth with decent

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Novartis AG NVS, a Swiss pharma giant, is scheduled to report second-quarter 2025 results on July 17.

The Zacks Consensus Estimate for revenues is pegged at $14.04 billion, while the same for

Aeva Technologies AEVA is certainly turning heads, especially with big news about its new partnership with Sandia National Laboratories. This collaboration aims to help secure U.S. nuclear reactor

GE Aerospace GE is scheduled to release second-quarter 2025 results on July 17, before market open. The Zacks Consensus Estimate for earnings is currently pegged at $1.43 per share on revenues of

Quanta Services, Inc. PWR is aligning its strengths with rising utility investment, grid modernization and the push for U.S.-based energy and manufacturing capacity while the Inflation Reduction Act